Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2012
DOI: 10.1016/j.msec.2012.07.006
|View full text |Cite
|
Sign up to set email alerts
|

Silver nanoparticles modified nanocapsules for ultrasonically activated drug delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(16 citation statements)
references
References 26 publications
0
15
0
Order By: Relevance
“…Notably, the capsules without NPs were only deformed after sonication. For a homogenous distribution of NPs, in situ synthesis of silver NPs in PAH/ DS capsules has also been reported [149]. The burst release of FITC-dextran within 5 s was observed upon exposure to ultrasonic irradiation of 170 W and 50 Hz.…”
Section: Laser Light Irradiationmentioning
confidence: 89%
“…Notably, the capsules without NPs were only deformed after sonication. For a homogenous distribution of NPs, in situ synthesis of silver NPs in PAH/ DS capsules has also been reported [149]. The burst release of FITC-dextran within 5 s was observed upon exposure to ultrasonic irradiation of 170 W and 50 Hz.…”
Section: Laser Light Irradiationmentioning
confidence: 89%
“…As a consequence of the difficulty encountered during AgNP synthesis and the concerns regarding the toxicity and reduced stability of nanosilver-based systems when functionalized according to conventional salt-aging techniques, silver is not extensively used in nanoparticle-based drug-delivery applications, instead being replaced with gold or other nanomaterials [ 88 ]. An excellent triggerable and tunable nanosystem for drug-delivery applications should be easy to develop from readily available components, exhibit optimal responsiveness, and be compatible with more than one trigger [ 89 ]. Moreover, such a particular drug-delivery [ 90 ] platform should not only provide suitable and adjustable drug loading and releasing profiles, but should also enable [ 70 ] maximal therapeutic efficiency at concentrations below that of the sole biosubstance with side-effect minimization [ 91 , 92 ].…”
Section: Silver Nanoparticles For Drug-delivery Systemsmentioning
confidence: 99%
“…This trend was preserved for all samples, indicating no visible carrier effect on the morphology of the silver nanoparticles deposited on the nanofibers. 1 BET surface area, calculated using experimental points at relative pressures of (P/P0) 0.035-0.31, where P and P0 denote the equilibrium and saturation pressures of nitrogen, respectively; 2 Total pore volume calculated from the nitrogen volume adsorbed at P/P0 = 0.99; 3 Pore-size distribution curves were obtained from the adsorption branch using the Barrett-Joyner-Halenda (BJH) model with cylindrical pores.…”
Section: Microstructural Characterization Of Ag/cs/silica Nanofibersmentioning
confidence: 99%
“…Hybrid nanocomposites are an important platform for the preparation of new materials with advanced properties [1][2][3][4][5][6][7][8]. Noble metal nanostructures encapsulated within or deposited on biopolymers are of particular interest for human [9,10], sensing [11,12], and catalytic applications [13][14][15][16], as these types of materials combine the physicochemical features of noble metal nanostructures and the biological features of polymers [17,18].…”
Section: Introductionmentioning
confidence: 99%